Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
Cash from Operating Activities
Dexcom Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dexcom Inc
NASDAQ:DXCM
|
Cash from Operating Activities
$802.3m
|
CAGR 3-Years
17%
|
CAGR 5-Years
41%
|
CAGR 10-Years
68%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
40%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Dexcom Inc's Cash from Operating Activities?
Cash from Operating Activities
802.3m
USD
Based on the financial report for Mar 31, 2024, Dexcom Inc's Cash from Operating Activities amounts to 802.3m USD.
What is Dexcom Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
68%
Over the last year, the Cash from Operating Activities growth was 6%. The average annual Cash from Operating Activities growth rates for Dexcom Inc have been 17% over the past three years , 41% over the past five years , and 68% over the past ten years .